In addition, to hindering the initial trans-sinusoidal migration of CRC cells in vivo, IFNα-stimulated LSECs efficiently cross-presented nominal tumor antigens to naive CD8+ T cells in vitro, enabling degrees of T cell priming and effector differentiation that were comparable to those induced by professional APCs. The gene discussed is CD8A; the disease is neoplasm.